Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 91

Sort by

Sort Order Select

Journal Articles

Pharmacokinetics and cardiac impact of arsenic trioxide (ATO) oral solution (SDK001) under fasting, fed, and calcium carbonate co-administration conditions compared with intravenous ATO in patients with acute promyelocytic leukemia

Harinder Gill, Farhad Ravandi, Jessica Altman, Gail Roboz, Tony Wu, Garret Leung, Danelle James, Stephane Berthier, Yok-Lam Kwong

Blood (2025) 146 (Supplement 1): 1506.

https://doi.org/10.1182/blood-2025-1506

Published: 2025

Journal Articles

Treatment landscape and outcome of myeloproliferative neoplasms in asia: Interim analysis of the Asian myeloproliferative neoplasm registry

Vivian Li, Rita Yim, Paul Lee, Qi Zhang, Lynn Chin, Po Yan Chan, Chun Kei Au, Sharon Shi, Lester Au, Carmen Lee, Tony Wu, Garret Leung, Yok-Lam Kwong, Harinder Gill

Blood (2025) 146 (Supplement 1): 2041.

https://doi.org/10.1182/blood-2025-2041

Published: 2025

Journal Articles

Updated clinical data and biomarker analyses from the phase 1 study of DR-01, a non-fucosylated anti-CD94 antibody in patients with relapsed/refractory cytotoxic lymphomas

Blood (2025) 146 (Supplement 1): 3646.

https://doi.org/10.1182/blood-2025-3646

Published: 2025

Journal Articles

Clinical manifestations, risk factors and prognosis associated with central nervous system relapse after CAR-T therapy for R/R B-cell non-Hodgkin lymphoma: A multi-center analysis

Tianning Gu, Tingting Yang, Mengyu Zhao, Yetian Dong, Meng Zhu, Linghui Zhou, Mingming Zhang, Wenfa Huang, Lei Wang, Rongrong Chen, Delin Kong, Jiazhen Cui, Wenxiao Li, Lixin Wang, Yok Lam Kwong, He Huang, Yongxian Hu

Blood (2025) 146 (Supplement 1): 6340.

https://doi.org/10.1182/blood-2025-6340

Published: 2025

Journal Articles

Venetoclax in combination with hypomethylating agents are effective salvage therapy in relapse/refractory ETP-ALL and near-ETP-ALL

Carol Yuk-Man Cheung, Ho-Wan Ip, Rock Yuk-Yan Leung, Yok-Lam Kwong

Blood (2025) 146 (Supplement 1): 1552.

https://doi.org/10.1182/blood-2025-1552

Published: 2025

Journal Articles

Asciminib as monotherapy or adjunctive therapy for chronic myeloid leukaemia in blast phase

Carol Yuk-Man Cheung, Ho-Wan Ip, Yok-Lam Kwong

Blood (2025) 146 (Supplement 1): 7297.

https://doi.org/10.1182/blood-2025-7297

Published: 2025

Journal Articles

Real-world outcomes of eltrombopag-containing regimens as frontline treatment for aplastic anemia: A multi-center retrospective study

Stephen Sze Yuen Lam, Yu Yan Hwang, Joycelyn P.Y. Sim, Wai Pan Lau, June S.M. Lau, Bonnie Kho, Rosalina K.L. Ip, Shek Ying Lin, Chi Kuen Lau, Chung Yin Ha, Vivien Mak, Eric Tse, Yok-Lam Kwong

Blood (2025) 146 (Supplement 1): 4983.

https://doi.org/10.1182/blood-2025-4983

Published: 2025

Journal Articles

Modified Delphi Process to Develop Best Practice Recommendations for Myelofibrosis Management in Routine Clinical Practice in the Asia-Pacific Region (The APAC-MF Alliance)

Harinder Gill, Chul Won Choi, Hein Than, Hsin-An Hou, Chul Won Jung, Yok-Lam Kwong, Garret M. K. Leung, Melissa G. M. Ooi, Ponlapat Rojnuckarin, David M. Ross, Lee-Yung Shih, Katsuto Takenaka, Winnie Z. Y. Teo, Keita Kirito

Blood (2024) 144 (Supplement 1): 3678.

https://doi.org/10.1182/blood-2024-201402

Published: 2024

Journal Articles

Results of the Regimen Dime in Diffuse Large B-Cell Lymphoma with MYC over-Expression: A Retrospective Analysis

Tony Kwun Yat Wu, Thomas S Chan, Yu Yan Hwang, Karen Hoi Ki Tang, Garret Man Kit Leung, Carmen Lee, Harinder Gill, Eric Tse, Yok Lam Kwong

Blood (2024) 144 (Supplement 1): 6464.

https://doi.org/10.1182/blood-2024-204629

Published: 2024

Journal Articles

A Phase II Prospective Study Evaluating an L-Asparaginase Regimen, Simple, in Newly Diagnosed Extranodal NK/T Cell Lymphoma

Thomas S Chan, Yok-Lam Kwong, Eric Tse, Tony Kwun Yat Wu, Cheong Ngai

Blood (2024) 144 (Supplement 1): 4444.

https://doi.org/10.1182/blood-2024-205353

Published: 2024

Journal Articles

Glofitamab in Aggressive B Non-Hodgkin Lymphoma (B-NHL): A Real World Experience

Thomas Chan, Yok Lam Kwong, Eric Tse

Blood (2023) 142 (Supplement 1): 6254.

https://doi.org/10.1182/blood-2023-173916

Published: 2023

Journal Articles

Efficacy and Safety of Asciminib in Chinese Patients with Philadelphia Chromosome(Ph)-Positive Leukaemias

Yuk Man Cheung, Yok-Lam Kwong

Blood (2023) 142 (Supplement 1): 6383.

https://doi.org/10.1182/blood-2023-185578

Published: 2023

Journal Articles

A Clinical-Molecular Prognostic Scoring System for Myelodysplastic Syndrome in Asia - a Multicenter Study of the Asian Myeloid Working Group (AMWG)

Harinder Gill, Hsin An Hou, Paul Lee, Rita Yim, Xavier Cheng-Hong Tsai, Melissa Ooi, Tsz-Shing Hui, Radha Raghupathy, Lynn Chin, Lester Au, Vivian Li, Garret Man Kit Leung, Edmond Ma, Asif Javed, Ho-Wan Ip, Wee-Joo Chng, Wen-Chien Chou, Hwei-Fang Tien, Yok-Lam Kwong

Blood (2023) 142 (Supplement 1): 4598.

https://doi.org/10.1182/blood-2023-182750

Published: 2023

Journal Articles

Real-World Effectiveness of Asciminib in Patients with Chronic Myeloid Leukemia (CML) Harboring the T315I Mutation: A Global Chart Review Study of Patients Treated in the Asciminib Managed Access Program (MAP)

Dragana Milojkovic, Nicole Blijlevens, Yok-Lam Kwong, Uzma Zaidi, Fausto Castagnetti, Paolo Gallipoli, Maria Cristina Miggiano, Peter E Westerweel, Melissa Chen, M. Carmen Garcia Hernandez, William J. Kell, Pankit Vachhani, Neha Agarwal, Alessandra Colasante, Sridhar Meka, Aoife Smyth, Germano Ferreira, Jeroen J.W.M. Janssen

Blood (2023) 142 (Supplement 1): 4541.

https://doi.org/10.1182/blood-2023-181937

Published: 2023

Journal Articles

Ropeginterferon Alfa-2b for Pre-Fibrotic Primary Myelofibrosis and DIPSS Low/Intermediate-1 Risk Myelofibrosis: Durable Responses and Evidence of Disease Modification

Harinder Gill, Lester Au, Garret Man Kit Leung, Dorothy Tsai, Rita Yim, Lynn Chin, Vivian Li, Paul Lee, Albert Chun Fung Sin, Hsin An Hou, Chih-Cheng Chen, Yok Lam Kwong

Blood (2023) 142 (Supplement 1): 4562.

https://doi.org/10.1182/blood-2023-180922

Published: 2023

Journal Articles

An Entirely Oral Regimen of Oral-Arsenic Trioxide/All-Trans Retinoic Acid/Ascorbic Acid in Newly-Diagnosed Acute Promyelocytic Leukaemia (APL): Updated Results of an Ongoing Multicentre Trial

Harinder Gill, Rita Yim, Lynn Chin, Paul Lee, Vivian Li, Lester Au, Garret Man Kit Leung, Ka Leung Daniel Cheuk, Shau-Yin Ha, Chi Kong Li, Melissa Ooi, Wee-Joo Chng, Patrick Chu, Cyrus Kumana, Yok Lam Kwong

Blood (2023) 142 (Supplement 1): 157.

https://doi.org/10.1182/blood-2023-179644

Published: 2023

Journal Articles

Phase 2 Study to Assess the Safety and Efficacy of Bomedemstat (MK3543) in Combination with Ruxolitinib in Patients with Myelofibrosis

Harinder Gill, Lester Au, Garret Man Kit Leung, Dorothy Tsai, Rita Yim, Lynn Chin, Vivian Li, Paul Lee, Rock Yuk Yan Leung, Elaine Lee, Hugh Young Rienhoff Jr., Yok Lam Kwong

Blood (2023) 142 (Supplement 1): 621.

https://doi.org/10.1182/blood-2023-181971

Published: 2023

Journal Articles

Efficacy and Safety of Ropeginterferon Alfa-2b for Pre-Fibrotic Primary Myelofibrosis and DIPSS Low/Intermediate-1 Risk Myelofibrosis

Harinder Gill, Lester Au, Rita Yim, Lynn Chin, Vivian Li, Paul Lee, Garret MK Leung, Carmen Lee, Tony Kwun Yat Wu, Cheong Ngai, Ryan Ho, Albert Chun Fung Sin, Hsin-An Hou, Chih-Cheng Chen, Yok-Lam Kwong

Blood (2022) 140 (Supplement 1): 1522.

https://doi.org/10.1182/blood-2022-169613

Published: 2022

Journal Articles

Primary Results of Stimulus-MDS1: A Randomized, Double-Blind, Placebo-Controlled Phase II Study of TIM-3 Inhibition with Sabatolimab Added to Hypomethylating Agents (HMAs) in Adult Patients with Higher-Risk Myelodysplastic Syndromes (MDS)

Amer M. Zeidan, Kiyoshi Ando, Odile Rauzy, Mehmet Turgut, Ming-Chung Wang, Roberto Cairoli, Hsin-An Hou, Yok-Lam Kwong, Montserrat Arnan Sangerman, Stef Meers, Vinod A. Pullarkat, Valeria Santini, Kamel Malek, Flavia Kiertsman, Jiaying Lyu, Pedro Marques Ramos, Pierre Fenaux, Yasushi Miyazaki, Uwe Platzbecker

Blood (2022) 140 (Supplement 1): 2063–2065.

https://doi.org/10.1182/blood-2022-158612

Published: 2022

Journal Articles

Tisagenlecleucel Vs Standard of Care As Second-Line Therapy of Primary Refractory or Relapsed Aggressive B-Cell Non-Hodgkin Lymphoma: Analysis of the Phase III Belinda Study

Blood (2021) 138 (Supplement 2): LBA-6.

https://doi.org/10.1182/blood-2021-155068

Published: 2021

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Pharmacokinetics and cardiac impact of arsenic trioxide (ATO) oral solution (SDK001) under fasting, fed, and calcium carbonate co-administration conditions compared with intravenous ATO in patients with acute promyelocytic leukemia

Treatment landscape and outcome of myeloproliferative neoplasms in asia: Interim analysis of the Asian myeloproliferative neoplasm registry

Updated clinical data and biomarker analyses from the phase 1 study of DR-01, a non-fucosylated anti-CD94 antibody in patients with relapsed/refractory cytotoxic lymphomas

Clinical manifestations, risk factors and prognosis associated with central nervous system relapse after CAR-T therapy for R/R B-cell non-Hodgkin lymphoma: A multi-center analysis

Venetoclax in combination with hypomethylating agents are effective salvage therapy in relapse/refractory ETP-ALL and near-ETP-ALL

Asciminib as monotherapy or adjunctive therapy for chronic myeloid leukaemia in blast phase

Real-world outcomes of eltrombopag-containing regimens as frontline treatment for aplastic anemia: A multi-center retrospective study

Modified Delphi Process to Develop Best Practice Recommendations for Myelofibrosis Management in Routine Clinical Practice in the Asia-Pacific Region (The APAC-MF Alliance)

Results of the Regimen Dime in Diffuse Large B-Cell Lymphoma with MYC over-Expression: A Retrospective Analysis

A Phase II Prospective Study Evaluating an L-Asparaginase Regimen, Simple, in Newly Diagnosed Extranodal NK/T Cell Lymphoma

Glofitamab in Aggressive B Non-Hodgkin Lymphoma (B-NHL): A Real World Experience

Efficacy and Safety of Asciminib in Chinese Patients with Philadelphia Chromosome(Ph)-Positive Leukaemias

A Clinical-Molecular Prognostic Scoring System for Myelodysplastic Syndrome in Asia - a Multicenter Study of the Asian Myeloid Working Group (AMWG)

Real-World Effectiveness of Asciminib in Patients with Chronic Myeloid Leukemia (CML) Harboring the T315I Mutation: A Global Chart Review Study of Patients Treated in the Asciminib Managed Access Program (MAP)

Ropeginterferon Alfa-2b for Pre-Fibrotic Primary Myelofibrosis and DIPSS Low/Intermediate-1 Risk Myelofibrosis: Durable Responses and Evidence of Disease Modification

An Entirely Oral Regimen of Oral-Arsenic Trioxide/All-Trans Retinoic Acid/Ascorbic Acid in Newly-Diagnosed Acute Promyelocytic Leukaemia (APL): Updated Results of an Ongoing Multicentre Trial

Phase 2 Study to Assess the Safety and Efficacy of Bomedemstat (MK3543) in Combination with Ruxolitinib in Patients with Myelofibrosis

Efficacy and Safety of Ropeginterferon Alfa-2b for Pre-Fibrotic Primary Myelofibrosis and DIPSS Low/Intermediate-1 Risk Myelofibrosis

Primary Results of Stimulus-MDS1: A Randomized, Double-Blind, Placebo-Controlled Phase II Study of TIM-3 Inhibition with Sabatolimab Added to Hypomethylating Agents (HMAs) in Adult Patients with Higher-Risk Myelodysplastic Syndromes (MDS)

Tisagenlecleucel Vs Standard of Care As Second-Line Therapy of Primary Refractory or Relapsed Aggressive B-Cell Non-Hodgkin Lymphoma: Analysis of the Phase III Belinda Study

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only